391 - 400 of 8399 Results
Title
Year
- Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy2024OPENTitle: Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-024-03221-5Citation Count: 2
- Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts2024OPENTitle: Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00789-wBest OA location URL: https://doi.org/10.1038/s41531-024-00789-wCitation Count: 8
- VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A12024OPENTitle: VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A1Journal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202311189Best OA location URL: https://doi.org/10.1083/jcb.202311189Citation Count: 4
- Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort study2024OPENTitle: Impact of excessive daytime sleepiness on the progression of freezing of gait in de novo Parkinson’s disease: a cohort studyJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 46Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-024-07738-8Best OA location URL: https://doi.org/10.1007/s10072-024-07738-8Citation Count: 0
- Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's Disease2024OPENTitle: Topography of Cholinergic Nerve Terminal Vulnerability and Balance Self-Efficacy in Parkinson's DiseaseJournal Name: Journal of Integrative NeurosciencePublisher: IMR PressVol: 23Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.31083/j.jin2309178Citation Count: 1
- Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: a comparative study with tranylcypromine2024OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: a comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107158Citation Count: 1
- Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort2024OPENTitle: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 7Start Page: 1481End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240213Best OA location URL: https://doi.org/10.3233/jpd-240213Citation Count: 0
- Cross‐Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin America2024OPENTitle: Cross‐Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin AmericaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14214Citation Count: 0
-
OPENTitle: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PETJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-52298-2Citation Count: 2
- Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome2024OPENTitle: Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal SyndromeJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.30019Citation Count: 2